Ms. Ziyi Wang | Immunology of Infections | Best Researcher Award

Posted on by Pencis

Ms. Ziyi Wang | Immunology of Infections | Best Researcher Award

Ms. Ziyi Wang, Wenzhou Medical University, China.

Ms. Ziyi Wang is a researcher specializing in the immunology of infections, with a focus on understanding how the immune system responds to various pathogens. Currently pursuing a Master’s degree in Epidemiology and Medical Statistics at Wenzhou Medical University, she has made significant contributions to the study of infection-related biomarkers and immune responses. Ziyi’s research has earned her the Best Researcher Award, recognizing her innovative work in identifying immune mechanisms and biomarkers that could inform better diagnostics and treatments for infectious diseases. Her dedication to advancing the field has led to her publication of multiple research articles in peer-reviewed journals.

Professional Profiles

Scopus Profile

šŸ“šEducation

Ms. Ziyi Wang is currently pursuing a Masterā€™s degree in Epidemiology and Medical Statistics at Wenzhou Medical University in Wenzhou, Zhejiang, China. Her academic focus includes researching biomarkers related to diabetes and its complications, particularly in the context of diabetic retinopathy. She has gained a strong foundation in statistical analysis, epidemiological research methods, and disease modeling, with an emphasis on applying these skills to medical and public health issues. Her studies also integrate practical research experience, contributing to her ongoing work in diabetes-related research.

šŸ’¼Experience

Ms. Ziyi Wang is currently conducting research on biomarkers for diabetic retinopathy (DR), with a specific focus on the role of plasma OA levels. Her work aims to investigate how OA levels could serve as a potential biomarker for early detection and effective management of DR, a common and vision-threatening complication of diabetes. By employing various statistical methods and analytical approaches, her research seeks to better understand the relationship between OA levels and DR risk, contributing to improved diagnostic models and potential clinical interventions for patients with diabetes.

šŸ”¬Research Interest

Ms. Ziyi Wang’s research interests focus on biomarkers for diabetic retinopathy (DR), with a particular emphasis on their potential for early detection and effective management of the condition. She is dedicated to exploring the underlying mechanisms of diabetes complications and how specific biomarkers can be utilized for improved diagnosis and treatment. Additionally, her research seeks to identify and explore new treatment targets for DR, aiming to contribute to the development of more targeted and effective therapeutic strategies for managing this vision-threatening complication of diabetes.

šŸ‘©ā€šŸ«Technical Skills

Ms. Ziyi Wang is proficient in a wide range of technical skills, including statistical analysis, epidemiological modeling, and biomarker detection. She applies advanced statistical methods to analyze complex data and model disease patterns, particularly in the context of diabetes and its complications. Her expertise in biomarker detection allows her to identify key indicators that contribute to the early detection and management of conditions like diabetic retinopathy. Additionally, Ziyi is well-versed in various research methodologies, ensuring the rigorous design, execution, and analysis of her studies to produce reliable and impactful scientific results.

šŸŽ¤Academic Citations

Ms. Ziyi Wang has published three articles in academic journals, making significant contributions to the field of diabetes research, particularly in the area of biomarkers for diabetic complications. Her research focuses on identifying key biomarkers that can aid in the early detection and management of diabetes-related complications, such as diabetic retinopathy. These publications have helped expand the understanding of the role of biomarkers in diabetes and have provided valuable insights into potential diagnostic tools and treatment strategies, further advancing the knowledge in this critical area of medical research.

šŸ“‘Top Note Publications

Title: The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou

Authors: Wang, Y., Yang, Z., Li, J., Jin, M., Mao, G.
Publication Year: 2024
Citations: 0

Title: Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques

Authors: Che, M., Xia, Z., Jiang, D., Zheng, C., Mao, G.
Publication Year: 2023
Citations: 0

Title: Title: Anemia is independently associated with mortality in people living with human immunodeficiency virus/acquired immune deficiency syndrome: A propensity score matching-based retrospective cohort study in China

Authors:Ā Jin, M., Wang, Y., Li, J., Yang, Z., Mao, G.
Publication Year: 2023
Citations: 3

 

Prof Dr. Damalie Nakanjako | Immunology of Infections | Women Researcher Award

Posted on by Pencis

Prof Dr. Damalie Nakanjako | Immunology of Infections | Women Researcher Award

Prof Dr. Damalie Nakanjako, Makerere University, Uganda.

Prof. Dr. Damalie Nakanjako is a distinguished researcher in Immunology of Infections and a dedicated advocate for advancing women’s contributions to science. As a Professor of Medicine and a renowned immunologist, her research focuses on understanding immune responses to infectious diseases, particularly in resource-limited settings. She has made significant strides in studying HIV, tuberculosis, and other infections, contributing to innovative treatments and influencing global health policies. With numerous publications in high-impact journals, Prof. Nakanjako is internationally recognized for her leadership in research, clinical practice, and mentoring young scientists. Her groundbreaking contributions have positioned her as a leading voice in combating infections and improving health outcomes for vulnerable populations, while championing gender equity in research and academia.

Professional Profiles

Scopus Profile

OrcidĀ  Profile

šŸ“šEducation

Dr. Damalie Nakanjako’s education is marked by advanced training in medicine, biomedical sciences, and leadership. She earned her MBChB in Medicine and Surgery from Makerere University, Uganda in 1999, followed by a Master of Medicine (MMED) in Internal Medicine in 2005. She completed her PhD in Biomedical Sciences at the University of Antwerp, Belgium in 2010. In addition to her degrees, she has specialized in leadership and governance, earning a Certificate in Corporate Governance and a Certificate in Audit and Risk Management from the Institute of Corporate Governance of Uganda in 2022 and 2023. Dr. Nakanjako also holds a Certificate in Leadership and Management in Health from the University of Washington, USA (2015). She has participated in key workshops, such as the Functional Genomics and Systems Biology Workshop at the Uganda Virus Research Institute (2014), and a Post-Doctoral Fellowship there from 2012 to 2013. Her commitment to professional development includes clinical research training through the Infectious Diseases Institute and GloCal Health Institute.

šŸ’¼Experience

Dr. Nakanjako has over 10 years of leadership experience in academia, serving as the Principal of Makerere University College of Health Sciences and Former Dean of the School of Medicine. She has also led collaborative research and training programs aimed at building Africa’s scientific capacity in Infection and Immunity.

 

šŸ”¬Research Focus

Dr. Nakanjako is a renowned researcher in Infection and Immunity, with extensive expertise in HIV care, treatment, and prevention in sub-Saharan Africa. Her research focuses on chronic HIV-associated inflammation, immune aging, and non-AIDS illnesses, as well as the use of mobile health (m-health) platforms for patient follow-up. She has published over 107 scientific papers and authored books such as Efficient HIV/AIDS Care in Resource-Limited Settings.

 

šŸ‘©ā€šŸ«Mentorship and Networking

A mentor to over 58 graduate students and post-doctoral researchers, Dr. Nakanjako is actively involved in programs like the Makerere University-Uganda Virus Research Institute Infection and Immunity (MUII) and the Afya Bora Consortium. She is also the director of the ADAPT One Health network, working on antimicrobial stewardship in sub-Saharan Africa.

 

šŸ†Awards

Dr. Nakanjako has received several prestigious awards throughout her career, including the TWAS-Abdool Karim Award in Biological Sciences (2022), which recognizes outstanding contributions to the field of biological sciences. In 2013, she was honored with the Fourth Annual Merle A. Sande Health Leadership Award for her leadership in health sciences. Additionally, she earned the Young Investigator Award at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) (2011), highlighting her early and impactful contributions to medical research.

šŸ“‘Top Note Publications

Title: Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study

Authors: Musiime-Mwase F, Nakanjako D, Kanywa JB, Sewankambo N, Elyanu P.
Publication Year: 2024
Citations: 0

Title: Barriers and facilitators of cervical cancer screening literacy among rural women with HIV attending rural public health facilities in East Central Uganda: a qualitative study using the integrated model of health literacy

Authors: Namutundu J, Kiguli J, Nakku-Joloba E, Nakanjako D, Nakalembe M.
Publication Year: 2024
Citations: 0

Title: The clinical utility of cystatin C based eGFR in assessing renal function among HIV/AIDS patients on ART at Mildmay Uganda

Authors: Wekiya E, Mujuzi GP, Nakiyingi J, Mutebi EI, Nakanjako D.
Publication Year: 2024
Citations: 0

Title: Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort

Authors: Nakanjako D, Nabatanzi R, Ssinabulya I, Banturaki G, Castelnuovo B.
Publication Year: 2024
Citations: 0

Title: Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda

Authors: Nanyeenya N, Nakanjako D, Makumbi F, Huzaifah M, Kiwanuka N.
Publication Year: 2024
Citations: 2